Stock Scorecard
Stock Summary for MeiraGTx Holdings plc (MGTX) - $5.84 as of 12/20/2024 3:48:33 PM EST
Total Score
8 out of 30
Safety Score
30 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for MGTX
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for MGTX
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for MGTX
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for MGTX
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for MGTX (30 out of 100)
Stock Price Rating (Max of 10) | 4 |
Historical Stock Price Rating (Max of 10) | 6 |
Stock Price Trend (Max of 10) | 1 |
Book Value (Max of 10) | 3 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 3 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 9 |
Price to Earnings (Max of 10) | 0 |
Latest News for for MGTX
Financial Details for MGTX
Company Overview |
|
---|---|
Ticker | MGTX |
Company Name | MeiraGTx Holdings plc |
Country | USA |
Description | MeiraGTx Holdings plc, a clinical-stage gene therapy company, focused on developing treatments for patients living with serious illnesses. The company is headquartered in New York, New York. |
Sector Name | LIFE SCIENCES |
Industry Name | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
Most Recent Quarter | 9/30/2024 |
Next Earnings Date | 3/12/2025 |
Stock Price History |
|
Last Day Price | 5.84 |
Price 4 Years Ago | 15.14 |
Last Day Price Updated | 12/20/2024 3:48:33 PM EST |
Last Day Volume | 1,196,777 |
Average Daily Volume | 268,023 |
52-Week High | 7.60 |
52-Week Low | 3.85 |
Last Price to 52 Week Low | 51.69% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 125.61 |
Sector PE | 40.44 |
5-Year Average PE | -6.16 |
Free Cash Flow Ratio | 3.72 |
Industry Free Cash Flow Ratio | 15.99 |
Sector Free Cash Flow Ratio | 27.17 |
Current Ratio Most Recent Quarter | 2.34 |
Total Cash Per Share | 1.57 |
Book Value Per Share Most Recent Quarter | 2.17 |
Price to Book Ratio | 5.02 |
Industry Price to Book Ratio | 5.62 |
Sector Price to Book Ratio | 20.63 |
Price to Sales Ratio Twelve Trailing Months | 59.18 |
Industry Price to Sales Ratio Twelve Trailing Months | 14.60 |
Sector Price to Sales Ratio Twelve Trailing Months | 24.53 |
Analyst Buy Ratings | 2 |
Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
Total Shares Outstanding | 78,153,000 |
Market Capitalization | 456,413,520 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 35.17% |
Reported EPS 12 Trailing Months | -1.20 |
Reported EPS Past Year | -1.63 |
Reported EPS Prior Year | -2.31 |
Net Income Twelve Trailing Months | -88,177,000 |
Net Income Past Year | -84,027,000 |
Net Income Prior Year | -129,615,000 |
Quarterly Revenue Growth YOY | -92.00% |
5-Year Revenue Growth | 13.34% |
Operating Margin Twelve Trailing Months | -162.80 |
Balance Sheet |
|
Total Cash Most Recent Quarter | 122,873,000 |
Total Cash Past Year | 129,566,000 |
Total Cash Prior Year | 115,516,000 |
Net Cash Position Most Recent Quarter | 49,931,000 |
Net Cash Position Past Year | 57,447,000 |
Long Term Debt Past Year | 72,119,000 |
Long Term Debt Prior Year | 71,295,000 |
Total Debt Most Recent Quarter | 72,942,000 |
Equity to Debt Ratio Past Year | 0.66 |
Equity to Debt Ratio Most Recent Quarter | 0.57 |
Total Stockholder Equity Past Year | 138,177,000 |
Total Stockholder Equity Prior Year | 117,738,000 |
Total Stockholder Equity Most Recent Quarter | 95,736,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -102,533,000 |
Free Cash Flow Per Share Twelve Trailing Months | -1.31 |
Free Cash Flow Past Year | -125,539,000 |
Free Cash Flow Prior Year | -118,061,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.02 |
MACD Signal | 0.07 |
20-Day Bollinger Lower Band | 3.10 |
20-Day Bollinger Middle Band | 5.19 |
20-Day Bollinger Upper Band | 7.29 |
Beta | 1.25 |
RSI | 44.26 |
50-Day SMA | 5.35 |
150-Day SMA | 6.93 |
200-Day SMA | 9.19 |
System |
|
Modified | 12/21/2024 6:09:54 AM EST |